Rezaee Michael E, Nichols Elizabeth L, Sidhu Mandeep, Brown Jeremiah R
Internal Medicine, Oakland University William Beaumont School of Medicine, Rochester, Michigan.
The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Lebanon, New Hampshire.
Clin Cardiol. 2016 Nov;39(11):658-664. doi: 10.1002/clc.22579. Epub 2016 Oct 21.
Pulmonary hypertension (PH) is a well-recognized complication of left ventricular heart failure (HF).
Differences exist in demographic, clinical, hemodynamic, and survival characteristics of patients with left ventricular HF who have combined postcapillary and precapillary PH (CpcPH), isolated postcapillary PH, or no PH.
A secondary data analysis was conducted using a large prospective database of patients undergoing right heart catheterization from 1994 to 2012. One-year mortality postcatheterization was assessed between PH groups using Kaplan-Meier and log-rank techniques, as well as a multivariate Cox proportional hazards model adjusted for age, sex, diabetes, chronic kidney disease, atrial fibrillation, and chronic obstructive pulmonary disease. Mortality rates were calculated for each group as deaths per 100 person-years.
Of the 724 patients identified, 29.4% (n = 213) had no evidence of PH, 63.1% (n = 457) had isolated postcapillary PH, and 7.5% (n = 54) had CpcPH. Compared with no PH, there was an increased mortality rate within 1 year for CpcPH patients (crude hazard ratio: 5.22, 95% confidence interval: 2.06-13.22), but not for isolated postcapillary PH patients (crude hazard ratio: 2.12, 95% confidence interval: 0.99-4.57). Adjusted analyses revealed similar results. Mortality rates per 100 person-years were 3.9, 8.4, and 21.0 for no PH, isolated postcapillary PH, and CpcPH patients, respectively.
Heart failure patients with CpcPH are associated with increased death rate 1 year post-cardiac catheterization, compared with patients without PH. They are a high-risk PH group and should be evaluated and diagnosed earlier in the disease state.
肺动脉高压(PH)是左心室心力衰竭(HF)一种公认的并发症。
合并毛细血管后和毛细血管前性PH(CpcPH)、孤立性毛细血管后性PH或无PH的左心室HF患者在人口统计学、临床、血流动力学和生存特征方面存在差异。
使用1994年至2012年接受右心导管检查患者的大型前瞻性数据库进行二次数据分析。使用Kaplan-Meier法和对数秩检验技术以及针对年龄、性别、糖尿病、慢性肾病、心房颤动和慢性阻塞性肺疾病进行调整的多变量Cox比例风险模型,评估PH组之间导管检查后1年的死亡率。计算每组每100人年的死亡率。
在724例确诊患者中,29.4%(n = 213)无PH证据,63.1%(n = 457)有孤立性毛细血管后性PH,7.5%(n = 54)有CpcPH。与无PH患者相比,CpcPH患者1年内死亡率增加(粗风险比:5.22,95%置信区间:2.06 - 13.22),但孤立性毛细血管后性PH患者死亡率未增加(粗风险比:2.12,95%置信区间:0.99 - 4.57)。调整分析显示了类似结果。无PH、孤立性毛细血管后性PH和CpcPH患者每100人年的死亡率分别为3.9、8.4和21.0。
与无PH患者相比,CpcPH心力衰竭患者在心脏导管检查后1年死亡率增加。他们是高危PH组,应在疾病状态下更早进行评估和诊断。